Hunter Jensen is currently the Director of Capital Project Engineering for the Nucleic Acids Solutions Division at Agilent Technologies, overseeing a $725 million greenfield build of an oligonucleotide GMP manufacturing facility. Previously, Hunter held various engineering and management roles at Novartis and Anheuser-Busch InBev, where they contributed to operations reliability and project engineering. Hunter earned a Bachelor of Applied Science in Mechanical Engineering from the University of Colorado at Boulder.
This person is not in the org chart
This person is not in any teams
This person is not in any offices